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Defense systems against infectious agents can be subdivided into
two broad categories involving
humoral and cellular mechanisms.
Specific humoral systems comprise
the antimicrobial and antitoxic effects of at least three classes (lgG,
lgM and lgA) of immunoglobulins. These immunoglobulins in
varying patterns may (a) neutralize toxins, (b) neutralize viral infectivity and ( c) kill certain gramnegative microorganisms in concert with the complement system.
A few microorganisms having
"deficient" cell walls, such as mycoplasma, may be inhibited by specific
antibodies without the aid of complement. Since lgA does not fix
complement, lgG and lgM must
play the dominant role in complement mediated reactions. A fourth
( d) category of specific immunoglobulin activity involves enhancement of phagocytosis or
opsonic action, which illustrates an
important interplay between a
specific humoral mechanism and
phagocytic mechanisms. It is probable that lgG and lgM also play
the dominant role in opsonization,
because lgA has been reported to
lack opsomzmg activity (Quie,
Messner and Williams, 1968). The
major functions of lgA must be to
neutralize toxins and the infectivity
of viruses.
In addition to specific humoral
mechanisms, several nonspecific hu-
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moral defense mechanisms exist.
Two such factors are ,8-lysin, which
is released during blood clot formation (Tew, Hess and Donaldson, 1969), and lysozyme, which is
probably secreted and/or released
from several cell types. It is significant that lysozyme can act in concert with the antibody-complement
system and augment the bactericidal and lytic effects of this system against certain gram-negative
microorganisms (Amano et al.,
1954). Lysozyme is usually present in lysosomes of phagocytic cells
and may be secreted by mononuclear cells (Heise and Myrvik,
1967). Other potentially active
nonspecific factors secreted from
living cells or released from disrupted and necrotic cells include
cationic substances, lactate, interferon, viral inhibitors and a recently described antibacterial system
involving
peroxidase,
thiocyanate and H20• (Hirsch,
1960; Klebanoff, Clem and Luebke,
1966; Wolstenholme and O'Connor, 1967; Zeya and Spitznagel,
1968).
If a microorganism is not inactivated by the humoral mechanisms present in the microenvironment at the site of infection,
phagocytic cells promptly come
into play, and, if conditions permit,
the infecting microorganisms will
be ingested. The polymorphonuclear (PMN) cell is usually the
first line of phagocytic cells to engage microorganisms. However, if
the infection continues and is not
contained by the PMNs, mononuclear phagocytes (macrophages)

49

DEFENSE MECHANISMS AGAINST INFECTIOUS DISEASES

eventually engulf the parasite and,
if necessary, can enter into a longterm engagement with the infectious agent. During this interaction
both nonspecific and specific humoral factors may participate prior
to and perhaps even conjointly with
the intracellular events. It is generally considered that the phagosomes in PMNs and macrophages
receive antibacterial factors and
hydrolytic enzymes from lysosomes
as the result of a fusion process
between lysosomes and the membrane surrounding the phagocytized particle (Hirsch, 1962).
It would be expected that the
least virulent of all microorganisms might be highly susceptible
to the nonspecific humoral systems
of defense. Such microorganisms
would be represented by Sarcina
lutea (sensitive to lysozyme) and
Bacillus subtilis (sensitive to /3lysin). The next hierarchy of pathogenic microorganisms to evolve
would be expected to be resistant
to the humoral mechanisms and
capable of resisting phagocytosis
unless specific opsonizing antibody
is present. Diplococcus pneumoniae is a representative of this type
of host-parasite relationship. However, D. pneumoniae is fully susceptible to the normal intracellular
bactericidal mechanisms once the
organism has been ingested. In this
case there is no evidence that
specific opsonizing antibody contributes significantly to the normal
intracellular bactericidal and digestive activities of PMNs and
macrophages except for mediating
phagocytosis.
The ultimate evolutionary step
reached by microorganisms has involved not only resistance to the
humoral systems of defense, but
also resistance to the normal baseline cellular systems of defense.
Mycobacterium tuberculosis is a
classic example of a parasite reaching this stage of host-parasite evolution. In fact, all of our so-called
chronic granulomatous diseases
(tuberculosis, brucellosis, listeriosis, histoplasmosis, tularemia,
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etc.) are chronic and granulomatous because of a persisting intracellular infection of the phagocytic
cells of the reticuloendothelial system. Characteristically the infectious lesion in these host-parasite
relationships is composed primarily
of macrophages, epithelioid cells,
giant cells and lymphoid cells.
Macrophages in a "status quo"
nonimmunized animal are essentially incapable of resisting the intracellular growth of virulent tubercle bacilli. Furthermore, the
PMNs fail, in all probability, because their life span is too short
to effectively bring to bear their
bactericidal and digestive systems
against an organism with such
challenging substrates and biochemical armor as the virulent
tubercle bacillus. Accordingly, the
ultimate in parasite evolution has
resulted in microorganisms with
complex cell walls and "capsular"
substrates that are refractory to
the normal bactericidal and/ or
digestive processes of the phagocytic cell systems. An alternative
to this possibility could involve
toxic moieties secreted or released
intracellularly by a pathogenic
microorganism which could disrupt
the chain of events leading to an
effective phagosome or block differentiation to an increased immunologic potential.
In this regard, PMNs are quite
capable of digesting Mycobacterium smegmatis within three hours,
which illustrates their potential for
killing an avirulent species of
mycobacteria (Leake and Myrvik,
1966).
Consequently,
virulent
mycobacteria are biochemically
structured in a way which allows
them to survive the intracellular
potential of the PMN and makes
them candidates ultimately for
phagocytosis by macrophages. Normal macrophages appear to undergo a form of non-immunologic
mediated differentiation and can
kill M. smegmatis after about
four to six days of intracellular
residence. However, macrophages
can cope only with virulent myco-

bacteria after they have differentiated in vivo under the blanket of an
immunologic stimulus. Accordingly,
there is good evidence to support
the concept that normal macrophages are relatively immature
cells and can differentiate upon
demand by either stimulation with
"substrate" or some specific immunological mechanism (Evans
and Myrvik, 1968) . In addition,
these forms of stimulation may
lead to mitosis, resulting in a more
favorable host cell-parasite ratio.
Undoubtedly, macrophages activated by a specific immunologic
mechanism develop a population
of "immune" phagocytes sooner
than by way of the "substrate"
principle of stimulation. For example, sodium stearate will develop a characteristic epithelioid
cell granuloma which has the same
rate of formation regardless of the
number of injections. In contrast,
repeated injections of mycobacteria
illustrate the development of socalled accelerated or allergic granu lo mas (Myrvik, Leake and
Oshima, 1962) .
The PMN normally emerges
from the bone marrow as a mature
cell with a constitutive load of
antibacterial and digestive factors
packaged in lysosomes. It thus appears that opsonizing antibody is
the main specific immunologic
component that interplays directly
with the PMN. It is also feasible
in certain instances for bactericidal
antibody plus complement to interplay with lysozyme and, possibly,
other antibacterial agents that are
transferred to the phagosome. In
addition, certain components of
complement have been demonstrated to exert positive chemotactic
effects on PMNs (Mi.iller-Eberhard,
1968). However, chemotaxis of
PMNs also can be prompted by
components resulting from tissue
damage apart from specific antigenantibody-complement reactions or
other specific sensitivity responses.
~There is no evidence that PMNs
proliferate in tissues as a result of
a specific immunologic stimulus.
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Therefore, mobilization to any lesion is dependent on blood-borne
transport.
In contrast, macrophages commonly circulate or exist in tissues
as relatively undifferentiated cells
with a sparse number of lysosomes
and a low level of hydrolases as
well as a baseline level of metabolic
activity (Heise, Myrvik and Leake,
1965; Myrvik and Evans, 1967;
Leake and Myrvik, 1968). It is
of interest that normal alveolar
macrophages, even of a low order
of activation, can readily kill and
digest avirulent strains of Listeria
monocytogenes but not virulent
strains of this organism (Evans,
1968). However, BCG-(Mycobacterium bovis) activated alveolar
macrophages are capable of killing
virulent strains of L. monocytogenes. These findings indicate that,
once a macrophage is activated by
interaction with one type of microorganism, it also has an increased
potential to contain and destroy
certain unrelated microorganisms.
It should be emphasized that this
generalization does not hold when
BCG-activated macrophages are
presented with virulent Pasteurella
tularensis. On the other hand,
macrophages from P. tularensisvaccinated animals are capable of
handling P. tularensis (Nutter and
Myrvik, 1966).
Whereas the role of specific
antibodies and their interplay with
PMNs is reasonably well understood, our concepts concerning the
interplay of specific antibodies and
acquired immunity to facultative
intracellular parasites (the ultimate
in evolution of microbial pathogens) is obscure. Speculation is
our only modus operandi for discussing this facet of cellular immunity. There is compelling evidence that with most facultative
intracellular parasites opsonizing
antibody is not the limiting factor. For example, there appears
to be an adequate concentration
of opsonins in normal sera for mycobacteria and listeria. These opsonins could be the result of long-

term contact with similar or related
organisms in the environment. Accordingly, opsonins (if needed with
these organisms) are usually normally present, and, thus, phagocytic
uptake by macrophages is not the
limiting step following primary infection with these organisms. This
does not exclude the possibility that
phagocytosis of some facultative intracellular parasites may be dependent on antibodies present only in
the specifically immune host. Nevertheless, the key point in our understanding of the host-parasite
relationship in the so-called granulomatous diseases rests on the fact
that normal macrophages are
incapable of suppressing the intracellular parasite even if sufficient
time is allowed for "substrate"
activation. This is exemplified in
the case of tuberculosis, where the
generation time of the parasite is
probably two to four days in vivo.
In this host-parasite relationship, it
is quite apparent that only immune
macrophages can significantly suppress the growth of tubercle
bacilli.
Assuming that the macrophages
which mediate immunity to tuberculosis are derived as the result of
some specific immunologic activation process, an interplay of specific and nonspecific factors in
cellular immunity must be postulated.
Current knowledge in this area
supports the concept that immune
lymphocytes are activated following contact with the corresponding
antigen. As a result, these lymphocytes undergo transformation and
secrete either specific antibody with
cytophilic properties for macrophages or a product (Granger's
lymphotoxin?) which can activate
macrophages (Granger and Kolb,
1968; Heise, Han and Weiser,
1968). If cytophilic antibody is involved, the macrophages passively
receive a recognition system ( cytophilic antibody) which could function to specifically activate macrophages when they have made contact with the appropriate antigen.

On the other hand, if a nonspecific
secretion product of the specifically
activated immune lymphoid cells is
responsible, specificity of the response would not exist on the
macrophage level. However, it is
unlikely that the effector cell
(macrophage) of antibacterial cellular immunity is totally devoid of
specific components. Cytophilic
antibodies on macrophages could
function in an "antitoxic" capacity
on the intracellular level.. This
possibility is best exemplified by
the lack of immune expression of
BCG-activated (immune) macrophages against P. tularensis. In contrast, macrophages derived from P.
tularensis-immune animals express
definite cellular immunity against
P. tularensis. The possibility that
certain types of antibody could
function on the intracellular level
to protect the macrophage against
toxic products secreted by intracellular pathogens warrants investigation.
In transplantation immunity it
appears likely that immune lymphoid cells act directly as effector
cells. In this case, macrophages
may act only as a secondary participant, which is in contrast to the
primary role macrophages play in
antibacterial cellular immunity.
The case for a lymphotoxin being
an effector agent in transplantation
immunity is attractive and deserves
further study.
Summary

The total complex of immune
expression is an interplay between
nonspecific antimicrobial humoral
systems plus specific antibodies and
accessory factors. These systems
are backstopped by the phagocytic
functions of PMNs. If these fail,
mononuclear phagocytes respond
as a second line of defense to
carry out chronic engagements. In
addition to a direct activation process by "substrate," macrophages
may be activated and mobilized by
a lymphocyte-mediated immunologic reaction which probably in51
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volves either a "lymphotoxin" and/
or a specific antibody cytophilic for
macrophages. Immunologically activated lymphocytes appear to be
the primary effector cells of antitissue (transplantation) cellular immunity, whereas immunologically
activated macrophages appear to be
the primary effector cells of antibacterial cellular immunity.
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